Global Pharmaceuticals & Biotech High Insider Buying

GSK

Market Cap: UK£71.2b

Engages in the research, development, and manufacture of vaccines, specialty medicines, and general medicines to prevent and treat disease in the United Kingdom, the United States, and internationally.

Illumina

Market Cap: US$18.6b

Provides sequencing- and array-based solutions for genetic and genomic analysis in the Americas, Europe, Greater China, the Asia Pacific, the Middle East, and Africa.

Summit Therapeutics

Market Cap: US$12.5b

A biopharmaceutical company, focuses on discovery, development, and commercialization of patient, physician, caregiver, and societal friendly medicinal therapies.

CSPC Pharmaceutical Group

Market Cap: HK$86.5b

An investment holding company, engages in the manufacture and sale of pharmaceutical products in Mainland China, other Asian regions, Europe, North America, and internationally.

Avantor

Market Cap: US$7.6b

Engages in the provision of mission-critical products and services to customers in the biopharma, healthcare, education and government, advanced technologies, and applied materials industries in the Americas, Europe, Asia, the Middle East, and Africa.

Axsome Therapeutics

Market Cap: US$7.4b

A biopharmaceutical company, develops and delivers novel therapies for the management of central nervous system (CNS) disorders in the United States.

Caris Life Sciences

Market Cap: US$6.7b

An artificial intelligence TechBio company, provides molecular profiling services in the United States and internationally.

Hikma Pharmaceuticals

Market Cap: UK£3.5b

Develops, manufactures, markets, and sells a range of generic, branded, and in-licensed pharmaceutical products.

Scholar Rock Holding

Market Cap: US$4.1b

A biopharmaceutical company, focuses on the discovery, development, and delivery of medicines for the treatment of serious diseases in which signaling by protein growth factors plays a fundamental role.

Grand Pharmaceutical Group

Market Cap: HK$29.0b

An investment holding company, engages in the research and development, manufacture, and sale of pharmaceutical preparations and medical devices, biotechnology and healthcare products, and pharmaceutical raw materials.

Kalbe Farma

Market Cap: Rp55.7t

Develops, manufactures, and trades in pharmaceutical products in Indonesia.

Edgewise Therapeutics

Market Cap: US$2.3b

A biopharmaceutical company, discovers, develops, and commercializes therapies for the treatment of muscle disorders.

Zai Lab

Market Cap: US$2.3b

A biopharmaceutical company, focuses on discovering, developing, and commercializing products that address medical conditions in the areas of oncology, immunology, neuroscience, and infectious diseases.

ChemoMetec

Market Cap: DKK 13.1b

Engages in the development, production, and sale of analytical equipment for cell counting and analysis the United States, Canada, Europe, and internationally.

Organon

Market Cap: US$2.0b

Develops and delivers health solutions through prescription therapies and medical devices in the United States, Europe, Canada, Japan, rest of the Asia Pacific, Latin America, the Middle East, Russia, Africa, and internationally.

Zenas BioPharma

Market Cap: US$1.9b

A clinical-stage biopharmaceutical company, engages in the development and commercialization of transformative immunology-based therapies.

Mesoblast

Market Cap: AU$2.9b

Engages in the development of regenerative medicine products in Australia, the United States, Singapore, and Switzerland.

Perrigo

Market Cap: US$1.8b

Provides over-the-counter health and wellness solutions in the United States, Europe, and internationally.

Dynavax Technologies

Market Cap: US$1.3b

A commercial stage biopharmaceutical company, focuses on developing and commercializing vaccines in the United States and internationally.

Biohaven

Market Cap: US$1.3b

Biohaven Ltd. discovers, develops, and commercializes therapies for immunology, neuroscience, and oncology worldwide.

CARsgen Therapeutics Holdings

Market Cap: HK$9.6b

An investment holding company, engages in discovering, developing, and commercializing chimeric antigen receptor T (CAR-T) cell therapies for the treatment of hematological malignancies, solid tumors, and autoimmune diseases in China.

Rapport Therapeutics

Market Cap: US$1.2b

Operates as a clinical-stage biopharmaceutical company that focuses on the discovery and development of transformational small molecule medicines for patients suffering from central nervous system (CNS) disorders.

MBX Biosciences

Market Cap: US$1.2b

A clinical-stage biopharmaceutical company, focuses on the discovery and development of precision peptide therapies for the treatment of endocrine and metabolic disorders.

Gubra

Market Cap: DKK 7.5b

A biotech company, focuses on the pre-clinical contract research and peptide-based drug discovery within metabolic and fibrotic diseases in Europe, North America, and internationally.

BioGaia

Market Cap: SEK 10.2b

A healthcare company, develops, manufactures, markets and sells probiotic products for gut, oral, and immune health in Europe, the Middle East, Africa, the United States, the Asia-Pacific, Australia, and New Zealand.

Intellia Therapeutics

Market Cap: US$981.1m

A clinical-stage gene editing company, focuses on the development of curative genome editing treatments.

MoonLake Immunotherapeutics

Market Cap: US$956.4m

A clinical stage biotechnology company, focuses on developing therapies for inflammatory skin and joint diseases.

Fortrea Holdings

Market Cap: US$942.5m

A contract research organization, provides biopharmaceutical product and medical device development solutions to pharmaceutical, biotechnology, and medical device customers worldwide.

Oxford Biomedica

Market Cap: UK£714.2m

A contract development and manufacturing organization, focuses on delivering therapies to patients worldwide.

Maravai LifeSciences Holdings

Market Cap: US$925.7m

A life sciences company, provides products that enable the development of drug therapies, vaccines, drug therapies, cell and gene therapies, and diagnostics North America, Europe, the Middle East, Africa, the Asia Pacific, and Latin and Central America.

LENZ Therapeutics

Market Cap: US$888.6m

Operates as a biopharmaceutical company that focuses on the development and commercialization of therapies to improve vision in the United States.

Arvinas

Market Cap: US$834.3m

A clinical-stage biotechnology company, engages in the discovery, development, and commercialization of therapies to degrade disease-causing proteins.

CorMedix

Market Cap: US$793.8m

A biopharmaceutical company, focuses on developing and commercializing therapeutic products for life-threatening diseases and conditions in the United States.

Jacobio Pharmaceuticals Group

Market Cap: HK$5.2b

An investment holding company, engages in the in-house discovery and development of oncology therapies.

MapLight Therapeutics

Market Cap: US$648.9m

Operates as a clinical-stage biopharmaceutical company for patients suffering from debilitating central nervous system disorders.

Swedencare

Market Cap: SEK 5.6b

Develops, manufactures, markets, and sells animal healthcare products for cats, dogs, and horses in North America, Europe, and internationally.